DCT
1:20-md-02930
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Log In
Overview
Analysis
General
Parties
Attorneys
Patents
Products
Related Cases
Dockets
General
Filed
03/27/20
Cause of Action
Patent Infringement
Sector
Biotech
Status
Open
Patent Owner
Operating Company
(W)
PACER
1:20-md-02930
Nature of Suit
835 ANDA
Appeals
23-2218
,
24-2209
,
24-2210
,
24-2211
,
24-2212
,
25-1722
,
25-1927
Court
D. Delaware
Judge
Period
PO Win Rate
Richard G. Andrews
--
36%
Plaintiff
Party
Name
Ratings
Novartis Pharmaceuticals Corp
L4
A
Show all (-1 more)
Attorney
Name
Ratings
Fitzpatrick Cella Harper & Scinto
L5
A
Christopher E. Loh
L5
B
Venable LLP
L5
A
Christina Schwarz
L5
B
Nicholas N. Kallas
L5
B
Susanne Flanders
L5
B
Jared Stringham
L5
B
Laura Fishwick
L4
B
Shannon Clark
L3
B
Gregory J. Manas
L3
B
McCarter & English LLP
L5
A
Daniel M. Silver
L5
A
Alexandra M. Joyce
L4
B
Show all (3 more)
Defendant
Party
Name
Ratings
Nanjing Noratech Pharmaceutical Co Ltd
L1
D
Gerbera Therapeutics Inc
--
--
--
Show all (0 more)
Attorney
Name
Ratings
Husch Blackwell LLP
L4
B
Thomas P. Heneghan
L5
B
Don J. Mizerk
L5
E
Avery Hitchcock
L2
D
Heyman Enerio Gattuso & Hirzel LLP
Local
L3
E
Dominick T. Gattuso
L5
E
Denise S. Kraft
L1
D
Show all (-3 more)